Efficacy of topical 2% cyclosporine A as a steroid-sparing agent in steroid-dependent vernal keratoconjunctivitis;Efficacité de la ciclosporine A en collyre à 2 % en tant qu'épargneur de corticoïdes dans le traitement de la kératoconjonctivite vernale corticodépendante

Journal Francais d'Ophtalmologie

Volumn 30, Issue 7, 2007, Pages 697-701

  Doan, S ^a,c   Gabison, E ^a   Abitbol, O ^a   Gatinel, D ^a   Chast, F ^b   Hoang Xuan, T ^a  

^a FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD   (France)

^b HÔTEL DIEU   (France)

^c BICHAT HOSPITAL   (France)

Author keywords

Allergy; Children; Cyclosporine; Immunosuppressive drugs; Vernal keratoconjunctivitis

Indexed keywords

EID: 34548675831     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0181-5512(07)91357-1     Document Type: Article

References (16)

1. Bonini S, Bonini S, Lambiase A, Marchi S, Pasqualetti P, Zuccaro O, et al. Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup. Ophthalmology, 2000;107:1157-63.
2. Tabbara KF. Ocular complications of vernal keratoconjunctivitis. Can J Ophthalmol, 1999;34:88-92.
3. BenEzra D, Pe'er J, Brodsky M, Cohen E. Cyclosporine eyedrops for the treatment of severe vernal keratoconjunctivitis. Am J Ophthalmol, 1986;101:278-82.
4. BenEzra D, Matamoros N, Cohen E. Treatment of severe vernal keratoconjunctivitis with cyclosporine A eyedrops. Transplant Proc, 1988;20:644-9.
5. Secchi AG, Tognon MS, Leonardi A. Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis. Am J Ophthalmol, 1990;110:641-5.
6. Bleik JH, Tabbara KF. Topical cyclosporine in vernal keratoconjunctivitis. Ophthalmology, 1991;98:1679-84.
7. Holland EJ, Olsen TW, Ketcham JM, Florine C, Krachmer JH, Purcell JJ, et al. Topical cyclosporin A in the treatment of anterior segment inflammatory disease. Cornea, 1993;12:413-9.
8. Mendicute J, Aranzasti C, Eder F, Ostolaza JI, Salaberria M. Topical cyclosporin A 2% % in the treatment of vernal keratoconjunctivitis. Eye, 1997;11(Pt1):75-8.
9. Gupta V, Sahu PK. Topical cyclosporin A in the management of vernal keratoconjunctivitis. Eye, 2001;15:39-41.
10. Pucci N, Novembre E, Cianferoni A, Lombardi E, Bernardini R, Caputo R, et al. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis. Ann Allergy Asthma Immunol, 2002;89:298-303.
11. Kosrirukvongs P, Luengchaichawange C. Topical cyclosporine 0.5 per cent and preservative-free ketorolac tromethamine 0.5 per cent in vernal keratoconjunctivitis. J Med Assoc Thai, 2004;87:190-7.
12. Chast F, Lemare F, Legeais JM, Batista R, Bardin C, Renard G. [Cyclosporine 2% eye drops preparation]. J Fr Ophtalmol, 2004;27:567-76.
13. Daniell M, Constantinou M, Vu HT, Taylor HR. Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis. Br J Ophthalmol, 2006;90:461-4.
14. Avunduk AM, Avunduk MC, Erdol H, Kapicioglu Z, Akyol N. Cyclosporine effects on clinical findings and impression cytology specimens in severe vernal keratoconjunctivitis. Ophthalmologica, 2001;215:290-3.
15. El Asrar AM, Tabbara KF, Geboes K, Missotten L, Desmet V. An immunohistochemical study of topical cyclosporine in vernal keratoconjunctivitis. Am J Ophthalmol, 1996;121:156-61.
16. Leonardi A. Vernal keratoconjunctivitis: pathogenesis and treatment. Prog Retin Eye Res, 2002;21:319-39.